Results 101 to 110 of about 19,524 (248)

Reduction of opioid and barbiturate use following initiation of rimegepant for migraine in the United States

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The primary objective of this study was to evaluate opioid and barbiturate utilization before and after the first prescription of the calcitonin gene–related peptide receptor antagonist rimegepant in individuals with migraine. Background Although not recommended in migraine treatment guidelines, opioids and barbiturates are often ...
Noah Rosen, Aaron Jenkins, Karin Hygge Blakeman, Feng Dai, Lucy Abraham, Chelsea Leroue, Josh Brown   +6 more
wiley   +1 more source

Efficacy Of Ondansetron, Granisetron And Palonosetron On Post operative Nausea and Vomiting in Patients undergoing Elective Neurosurgical Procedure

Basrah Journal of Surgery
Background Neurosurgery is associated with high incidence of PONV. 5HT3 Antagonists are highly specific for the treatment of nausea and vomiting. They are preferred antiemetic agents in neurosurgeries due to the lack of sedation and extrapyramidal ...
Vasudha Govil, Richa Malik , Prashant Kummar, Anju Rani , Sudha Puhal   +4 more
doaj   +1 more source

Using haloperidol as an anti-emetic in palliative care: informing practice through evidence from cancer treatment and post-operative contexts [PDF]

, 2013
YesNausea and vomiting are common symptoms in palliative care. Haloperidol is often used as an antiemetic in this context, although direct evidence supporting this practice is limited.
Alison Blenkinsopp, Büttner M, Chaparro LE, Chu CC, Cole DR, Critchley P, Depoortère R, Feng PH, Glare P, Grecu L, Hardy JR, Hsu WH, Janssen PAJ, Jha SK, Keeley PW, Kennett A, Lee Y, Lima L, Michael I. Bennett, Neidhart JA, Osinski MA, Perkins P, Rosow CE, Sadashivaiah R, Samantha L. McLean, Settle EC, Tramèr MR, Wang TF   +27 more
core   +1 more source

Acupuncture as an antiemetic [PDF]

BMJ, 1988
J W, Dundee, K R, Milligan
openaire   +2 more sources

New antiemetic drugs

Annals of Oncology, 2006
Important progress in the prophylaxis of chemotherapy-induced acute and delayed emesis has been achieved but some fundamental needs still remain that requires new, efficacious antiemetic drugs.A critical review of the results of published studies of aprepitant, a new NK1 receptor antagonist, and of palonosetron, a 5-HT3 receptor antagonist with a ...
F, Roila, S, Fatigoni
openaire   +2 more sources

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani, Larry Charleston IV, Shannon Strom, Detlef Albrecht, Robert Cowan   +4 more
wiley   +1 more source

Olanzapine –The cost-effective anti-emetic

Journal of Dr. NTR University of Health Sciences
Introduction: Chemotherapy induced nausea and vomiting can be distressing when not adequately controlled. Many agents are used prophylactically to prevent CINV (Chemotherapy induced nausea and vomiting).
R Ramesh Reddy, Ravi Chandran Ambalathandi, Haneesha Polavarapu, Manickavasagam Meenakshisundaram   +3 more
doaj   +1 more source

The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer [PDF]

, 2007
Annotated and edited transcript of a Witness Seminar held on 4 April 2006. Introduction by Professor Matti Aapro, Grenolier, Switzerland.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2007.©The Trustee of the Wellcome ...
Christie, DA, Tansey, EM
core  

Glucocorticoid administration in antiemetic therapy: Is it safe? [PDF]

, 2005
Hans Rutz, Ingrid Herr
openalex   +1 more source

Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People

Journal of the American Geriatrics Society, EarlyView.
This graphical abstract illustrates the annual prevalence of exposure to CPIC Level A drugs among older adults, categorized by type of pharmacogenetic recommendation. Data are presented per 1000 older individuals (A) and per 1000 prescriptions (B).
Zinan Zhao, Yuxuan Zhao, Xiaowen Hu, Xue Wang, Gengchen Wang, Xinyi Zhang, Wenliang Dong, Luwen Shi, Xiaodong Guan, Christine Y. Lu, Pengfei Jin, Xiaoyan Nie   +11 more
wiley   +1 more source